Delivery Order SPE2DB22D2006-SPE2DB24FW3BQ

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,561,342,095 units of the Typhim VI 25 MCG/0.5 ML vaccine, with a ceiling value of $17,208.40. The contract type is firm fixed price, and the ultimate completion date is June 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Typhim VI vaccine, a 25 mcg/0.5 mL vial in a 10 mL size. The contract has a firm fixed price of $2,888.05 and a completion date of December 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a $3,413.11 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The delivery order has an ultimate completion date of June 4, 2025. This contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $39,739.00 firm-fixed-price contract is for the supply of 4565427538 units of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,072,753 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $8,413.49 and a period of performance ending on April 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,449.50, is for the supply of Typhim VI, a 25 mcg/0.5 ml syringe vaccine. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug...
This firm-fixed-price delivery order, valued at $14,981.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,519.20, is for the supply of 4,568,062,424 units of the vaccine Typhim VI 25 MCG/0.5 ML SYRNG 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which allows AmerisourceBergen to provide a wide range of pharmaceutical...
This is a $68,833.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,562,207,182 units of the Typhim VI 25 mcg/0.5 mL vaccine, with a completion date of September 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This is a $2,759.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine and is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC enables the government to procure a wide range of pharmaceutical products and medical supplies, including...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW3BQ
    Delivery Order

This is a $3,939.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,549,323 units of the Typhim VI 25 mcg/0.5 mL vaccine. The contract has an ultimate completion date of August 23, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities, including prescription drugs and vaccines, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/21/24, 9:07 AM